Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1

Hormone and Metabolic Research

Volumn 39, Issue 3, 2007, Pages 179-185

  Maor, S ^a   Papa, M Z ^b   Yarden, R I ^b   Friedman, E ^c   Lerenthal, Y ^a   Lee, S W ^d   Mayer, D ^e   Werner, H ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

BRCA1; Breast cancer; IGF I; IGF I receptor; Sp1; Transcription

Indexed keywords

BRCA1 PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR SP1; ZINC FINGER PROTEIN;

ARTICLE; BREAST CANCER; CELL CYCLE PROGRESSION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MAMMARY GLAND; MOLECULAR INTERACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

BRCA1 PROTEIN; CELL CYCLE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS);

EID: 34147216821     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970415     Document Type: Article

References (32)

1. Surmacz E: Function of the IGF-I receptor in breast cancer. J Mamm Gland Biol Neoplasia 2000; 5: 95-105
2. Yee D, Lee AV: Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mamm Gland Biol Neoplasia 2000; 5: 107-115
3. Werner H, LeRoith D: The role of the insulin-like growth factor system in human cancer. Adv Cancel Res 1996; 68: 183-223
4. Osborne CK, Clemmons DR, Arteaga CL: Regulation of breast cancer growth by insulin-like growth factors. J Steroid Biochem Mol Biol 1990; 37: 805-809
5. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M: Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. The Lancet 1998; 351: 1393-1396
6. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT, Jr: Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrine Rev 1995; 16: 143-163
7. Baserga R: The IGF-I receptor in cancer research. Exp Cell Res 1999; 253: 1-6
8. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A, Baserga R: Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 1993; 90: 11217-11221
9. Heidenreich KA, Zeppelin T, Robinson LJ: Insulin and insulin-like growth factor I induce c-fos expression in postmitotic neurons by a protein kinase C-dependent pathway. J Biol Chem 1993; 268: 14663-14670
10. Dupont J, Fernandez AM, Glackin CA, Helman L, LeRoith D: Insulin-like growth factor I (IGF-I)-induced twist expression is involved in the anti-apoptotic effects of the IGF-I receptor. J Biol Chem 2001; 276: 26699-26707
11. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71
12. Wang Q, Zhang H, Fishel R, Greene MI: BRCA1 and cell signaling. Oncogene 2000; 19: 6152-6158
13. Yang X, Lippman ME: BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat 1999; 54: 1-10
14. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T: The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 1997; 60: 505-514
15. Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA: Growth retardation and tumour inhibition by BRCA1. Nature Gen 1996; 12: 298-301
16. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120-122
17. Idelman G, Glaser T, Roberts CT, Jr, Werner H: WT1-p53 interactions in IGF-I receptor gene regulation. J Biol Chem 2003; 278: 3474-3482
18. Arizti P, Fang L, Park I, Yin Y, Solomon E, Ouchi T, Aaronson SA, Lee SW: Tumor suppressor p53 is required to modulate BRCA1 expression. Mol Cell Biol 2000; 20: 7450-7459
19. Werner H, Bach MA, Stannard B, Roberts CT, Jr, LeRoith D: Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol Endocrinol 1992; 6: 1545-1558
20. Xu C-F, Chambers JA, Solomon E: Complex regulation of the BRCA1 gene. J Biol Chem 1997; 272: 20994-20997
21. Yee D, Jackson JG, Von Hoff DD, Ravdin PM: Case report: use of insulin-like growth factor-I gene expression to distinguish between breast and ovarian cancer. Am J Med Sci 1994; 307: 108-111
22. Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin G-Y, Abel KJ, Weber BL, Chodosh LA: The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nature Gen 1995; 11: 17-26
23. Satterwhite DJ, Matsunami N, White RL: TGF-beta1 inhibits BRCA1 expression through a pathway that requires pRb. Biochem Biophys Res Commun 2000; 276: 686-692
24. Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, Iglehart JD, Futreal PA, Marks JR: BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Diff 1996; 7: 711-715
25. Yarden RI, Pardo-Reoyo S, Sgagias M, Cowan KH, Brody LC: BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nature Gen 2002; 30: 285-289
26. Pore N, Liu S, Shu HK, Li B, Haas-Kogan D, Stokoe D, Milanini-Mongiat J, Pages G, O'Rourke DM, Bernhard E, Maity A: Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Cell Biol 2004; 15: 4841-4853
27. Kitadai Y, Yasue W, Yodozaki H, Kuniyasu H, Haruma K, Kajiyama G, Tahara E: The level of transcription factor Sp1 is correlated with the expression of EGF receptor in human gastric carcinomas. Biochem Biophys Res Commun 1992; 189: 1342-1348
28. Abramovitch S, Glaser T, Ouchi T, Werner H: BRCA1-Sp1 interactions in transcriptional regulation of the IGF-IR gene. FEBS Lett 2003; 541: 149-154
29. Maor SB, Abramovitch S, Erdos MR, Brody LC, Werner H: BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1. Mol Gen Metab 2000; 69: 130-136
30. Abramovitch S, Werner H: Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene. Horm Metab Res 2003; 35: 758-762
31. Seeger H, Huober J, Wallwiener D, Mueck AO: Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen. Horm Metab Res 2004; 36: 277-280
32. Fortunati N, Catalano MG: Sex hormone-binding globulin (SHBG) and estradiol cross-talk in breast cancer cells. Horm Metab Res 2006; 38: 236-240